Physician profile
David Penn
NPI 1992143812
$969.95
in general payments reported to CMS, 2019-2025
10 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.30 · 2022: $381 · 2023: $341 · 2024: $16.39 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $355.15 | 2022-2025 | General - Pain Management |
| Medtronic, INC. | $153.16 | 2021-2025 | Catalyft Pl Expandable Interbody System, Infinity Occipitocervical Upper Thoracic System |
| Si-Bone, INC. | $139.31 | 2022 | |
| Integra Lifesciences Corporation | $107.27 | 2022-2023 | Codman Certas, Codman Hakim, Cusa Clarity |
| Ossdsign USA Incorporated | $77.29 | 2023 | |
| Cerapedics INC. | $41.37 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Imperative Care, INC | $34.63 | 2023 | Zoom Rdl Radial Access System, 103cm |
| Abbvie INC. | $26.66 | 2022 | |
| Lemaitre Vascular, INC. | $18.72 | 2023 | Anastoclip Gc 8cm (Medium) |
| Depuy Synthes Sales INC. | $16.39 | 2024 | Spine & Trauma 3d Navigation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Penn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.